최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of Korean Medicine = 대한한의학회지, v.36 no.1, 2015년, pp.75 - 85
이대훈 (경희대학교 한의과대학 융합한의과학교실) , 한재민 (경희대학교 한의과대학 융합한의과학교실) , 양웅모 (경희대학교 한의과대학 융합한의과학교실)
Objectives: Type 2 diabetes mellitus is a metabolic disease characterized by insulin resistance and high blood glucose level from progressive insulin secretory defect. The rhizome of Atractylodes japonica Koidz. (AJ) has been used for treatment of retention of water in oriental medicine. The aim of ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
제 1형 당뇨병과 제 2형 당뇨병의 특징은 무엇인가? | 대표적인 대사성 질환 중 하나인 당뇨병은 인슐린 부족이나 조직의 인슐린 민감도가 떨어져서 생기게 되는 고혈당과 이에 수반되는 대사 장애가 특징인 질환으로 제 1형 당뇨병과 제 2형 당뇨병으로 구분된다4). 제 1형 당뇨병의 기전은 췌장의 β세포 파괴로 인슐린을 전혀 생성하지 못하게 되는 것이고, 제 2형 당뇨병은 인슐린 저항성으로 인해 간, 근육, 지방 세포 등에서 인슐린 작용이 저하돼 포도당을 효과적으로 연소하지 못해 발생하게 된다5). | |
현재 쓰이는 경구혈당강하제의 종류에는 어떠한 것들이 있는가? | 4%)가 경구혈당강하제를 이용한 치료를 받고 있다3). 현재 사용되고 있는 경구혈당강하제의 종류로는 sulfonylurea계 약물, meglitinide계 약물, biguanide계 약물, α-glucosidase 억제계통 약물, thiazolidinedion계 약물, DPP-4 억제 약물 등이 있다6). 그러나 이런 약들은 저혈당, 체중 증가, 소화기 장애, 부종 등 다양한 부작용이 동반되는 것으로 보고되고 있다7). | |
당뇨병이란 무엇인가? | 대표적인 대사성 질환 중 하나인 당뇨병은 인슐린 부족이나 조직의 인슐린 민감도가 떨어져서 생기게 되는 고혈당과 이에 수반되는 대사 장애가 특징인 질환으로 제 1형 당뇨병과 제 2형 당뇨병으로 구분된다4). 제 1형 당뇨병의 기전은 췌장의 β세포 파괴로 인슐린을 전혀 생성하지 못하게 되는 것이고, 제 2형 당뇨병은 인슐린 저항성으로 인해 간, 근육, 지방 세포 등에서 인슐린 작용이 저하돼 포도당을 효과적으로 연소하지 못해 발생하게 된다5). |
Mccarthy MI. Genomics, type 2 diabetes, and obesity. The New England Journal of Medicine. 2010;363(24):2339-2350.
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-846.
Korean diabetes association. Korea centers for disease control and prevention. Diabetes fact sheet in korea 2012.
Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabetic medicine: a journal of the British Diabetic Association. 1998;15(7):539-553.
American diabetes association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37(1):S14-S80.
Cheng AYY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. Canadian Medical Association journal. 2005;172(2):213-226.
Yale JF. Oral antihyperglycemic agents and renal disease: New agents, new concepts. Journal of the American Society of Nephrology. 2005;16:S7-S10.
Doo HK. Internal Medicine of Kidney System. Seongbosa. 2003:1131.
Kang SB, Kim GC. A pathological approach about symptoms of So-gal. The Journal of East-West Medicines. 1998;23(4):21-40.
Kang SB. The comparative study between the transformations of sogal and the complications of diabetes mellitus. The Journal of Korean Oriental Medical Society. 1998;19(2):137-152.
Editing commission of herbal medicine. Herbal medicine. Youngrimsa. 2007:331-332.
Ahn DK. Illustrated guide to korean herbal medicine. Kyohaksa. 2008:384.
Heo J. Donguibogam. Bubinmunhwasa. 2007:1952.
Choi KH, Jeong SI, Lee JH, Hwang BS, Kim SJ, Lee S, et al. Pharmacological mechanism responsible for the Atractylodes japonica-induced distal colonic contraction in rats. Phytomedicine. 2011;18:408-413.
Han YK, Jung HW, Park YK. The roots of Atractylodes japonica Koidzumi promote adipogenic differentiation via activation of the insulin signalong pathway in 3T3-L1 cells. BMC Complementary and Alternative Medicine. 2012;12:154
Chen F, Xiong H, Wang J, Ding X, Shu G, Mei Z. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats. Journal of ethnopharmacology. 2013;149(3):729-736.
Vogeser M, Konig D, Frey I, Predel HG, Parhofer KG, Berg A. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons. Clinical Biochemistry. 2007;40(13-14):964-968.
Catalano PM, Presley L, Minium J, Mouzon SHD. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care. 2009;32(40):1076-1080.
Han YK, Park YK. Effect of Atractylodis Rhizoma Alba water extract on streptozotocin-induced diabetes in rats. Journal of Korean Herbology. 2011;26(4):23-30.
Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. The Lancet. 2011; 378(9):169-181.
Adefegha SA, Oboh G, Adefegha OM, Boligon AA, Athayde ML. Antihyperglycemic, hypolipidemic, hepatoprotective and antioxidative effects of dietary clove (Szyzgium aromaticum) bud powder in a high-fat diet/streptozotocin-induced diabetes rat model. Journal of the science of food and agriculture. 2014;94(13):2726-2737.
Colberg SR, Albright AL, Blissmer BJ, Braun B, Chasan-Taber L, Fernhall B, et al. Exercise and Type 2 Diabetes. Medicine and Science in Sports and Exercise. 2010;42(12):2282-2303.
Hong SM, Park JH, Lim YH, Park YS, Kim DS, Choi WH, et al. The relationship between diabetic retinopathy and macrovascular complication in patients with type 2 diabetes. The Korean Journal of Medicine. 2011;81(3):351-358.
Chae HJ, Lee IS, Moon HY. Effects of Schizandra Cchinensis fruit extract on the hyperglycemia and hyperlipemia in streptozotocin-induced diabetic rats. Korean Society for Biotechnology and Bioengineering Journal. 2011;26(2):126-130.
Choi ES, Rhee EJ, Kim JH, Won JC, Park CY, Lee WY, et al. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and future risk of diabetes mellitus in korean men. Diabetes and Metabolism Journal. 2008;32(6):498-505.
Han JS, Back SH, Hur JU, Lin YH, Gildersleeve R, Shan J, et al. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nature cell biology. 2013; 15(5):481-490.
Dor Y, Glaser B. Beta-cell differentiation and type 2 diabetes. The New England Journal of Medicine. 2013;368(6):572-573.
Imamura F, Mukamal KJ, Meigs JB, Luchsinger JA, Ix JH, Siscovick DS, et al. Risk factors for type 2 diabetes mellitus preceded by beta-cell dysfunction, insulin resistance, or both in older adults. American Journal of Epidemiology. 2013;177(12):1418-1429.
Ryu HS, Park SY, Ma D, Zhang J, Lee W. The Induction of MicroRNA Targeting IRS-1 Is Involved in the Development of Insulin Resistance under Conditions of Mitochondrial Dysfunction in Hepatocytes. PloS one. 2011;6(3):e17343.
Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;.414(6865):799-806.
Hemi R, Yochananov Y, Barhod E, Kasher MM, Karasik A, Tirosh A, et al. p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance. Diabetes. 2011;60(4):1134-1145.
Ohshima K, Mogi M, Jing F, Iwanami J, Tsukuda K, Min LJ, et al. Direct angiotensin II type 2 receptor stimulation ameliarates insulin resistance in type 2 diabetes mice with $ppar{\gamma}$ activation. PloS one. 2012;7(11):e48387.
Olson AL, Pessin JE. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annual review of nutrition. 1996;16:235-256.
Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. The New England Journal of Medicine. 1999;341(4):240-246.
Kainulainen H, Breiner M, Schurmann A, Marttinen A, Virjo A, Joost HG. In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT4 in heart and various types of skeletal muscle from streptozotocin-diabetic rats. Biochimica et Biophysica Acta. 1994; 1225(3):275?282.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.